Results from the REMOVAL trial revealed reduction in the risk of cardiovascular disease among other benefits with metformin in type 1 diabetes patients.
Read More »Reducing Risk of Cardiovascular Events and Death By Lowering A1c
Study focused on type 2 diabetes patients who initiate metformin.
Read More »Effects of Adding Metformin to Insulin in Type 1 Children and Adolescents
A low-risk intervention with potentially high rewards.
Read More »Should You Use Metformin For Type 1’s?
This study is the first retrospective, long-term analysis of metformin as adjuvant therapy to insulin in patients with T1DM.
Read More »Metformin Linked to Increased Risk of Dementia and Parkinson’s Disease
Study finds connection between duration of therapy in senior patients and development of neurodegenerative disease.
Read More »Metformin and Aging
Study shows age-related comorbidities decreased in males over 65 who take metformin.
Read More »Metformin in Gestational Diabetes
Should metformin or glyburide, or a combination of both drugs, be the first-line treatment for gestational diabetes?
Read More »Metformin Not the Only Treatment for Prediabetes
Pioglitazone in people with insulin resistance, prediabetes or diabetes is associated with a decreased risk for major adverse cardiovascular events, study data shows.
Read More »Metformin Reduces Mortality in CKD, CHF, and CLD
FDA label update will increase drug use in persons with historical contraindications or precautions.
Read More »Can Metformin Prevent Colorectal Cancer for Type 2 Patients?
Meta-analysis found metformin therapy was associated with decreased risk for colorectal adenomas and colorectal cancer among T2 patients.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.